Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
Nadchodzące badania kliniczne
-
NCT04840316Jeszcze nie rekrutujęWarunki: Delirum; Complication,Postoperative
-
NCT04840329RekrutacyjnyWarunki: Endometriosis
-
NCT04840342Jeszcze nie rekrutujęWarunki: Hypertension; Mineralocorticoid Excess
-
NCT04840368Jeszcze nie rekrutujęWarunki: Aging; Type2 Diabetes
-
NCT04840394Jeszcze nie rekrutujęWarunki: Tumor, Solid
-
NCT04840420Jeszcze nie rekrutujęWarunki: Social Isolation
-
NCT04840485Jeszcze nie rekrutujęWarunki: Ankylosing Spondylitis
-
NCT04840589Jeszcze nie rekrutujęWarunki: Metastatic Malignant Solid Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Platinum-Resistant Ovarian Carcinoma; Refractory Ovarian Carcinoma
-
NCT04840602Jeszcze nie rekrutujęWarunki: Lymphoplasmacytic Lymphoma; Waldenstrom Macroglobulinemia
-
NCT04840615RekrutacyjnyWarunki: Mesothelioma
Recent CRA jobs
-
Sr Document Review Spec
-
Ctry Approval Associate
-
Start Up CRA
-
(Sr) Site Contract Specialist - France
-
Project & Budget Analyst - UK
-
Project Specialist I - Inside Sales ; AES
-
AD Biostatistics (remote or office)
-
Sr Mgr Pharmacokinetics - Europe
-
Biostatistics Dir (remote or office)
-
Programming Dir (remote or office)